Overview

Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention

Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
Randomized, double-blinded, placebo-controlled study in AS patients with subclinical or clinical heart failure undergoing treatment with TAVR.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Aarhus
Collaborator:
Aarhus University Hospital
Treatments:
Sodium-Glucose Transporter 2 Inhibitors